Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

Pfizer Inc. boosts its oncology pipeline with strategic control of PD-1/VEGF bispecific drugs via 3SBio deal. Click for more ...

The World Health Organization announced Tuesday it has officially adopted the first-ever "Pandemic Agreement," just as the ...

The COVID-19 crisis taught the world fundamental lessons about the importance of global cooperation to fight disease. But ...